HIK Hikma Pharmaceuticals Plc

RNS Number:4242T
Merrill Lynch Intl (DTG) Syndicate
01 November 2005


1 November 2005

                              Stabilisation notice

                   Hikma Pharmaceuticals plc (the "Company")
Global Offer (the "Global Offer") of 51,311,193 ordinary shares of 10 pence each
                                     of the
   Company (the "Ordinary Shares") at a price of 290 pence per Ordinary Share
(with over-allotment arrangements in respect of up to 2,565,560 Ordinary Shares)

Merrill Lynch International notifies you that it is the stabilising manager in
respect of the Global Offer announced on 1 November 2005 and may conduct
stabilising activities in relation to the Ordinary Shares in connection with the
above transaction.

Merrill Lynch International confirms the following:

1.         The securities to be stabilised are the Ordinary Shares (ISIN:
GB00B0LCW083) referred to above.  There are no associated instruments that are
subject to stabilisation;

2.         The stabilising manager is Merrill Lynch International (Contact: Mark
Gwynne; Telephone: 020 7995 3700);

3.         Stabilisation transactions may occur during the stabilisation period,
which is expected to commence at 8.00 am on 1 November 2005 and will end on 30
November 2005;

4.         The issue price of the Ordinary Shares (the "Issue Price") is 290
pence per Ordinary Share.  The Issue Price was determined at 6pm on 31 October
2005;

5.         In connection with the Global Offer, Merrill Lynch International, as
stabilising manager, has entered into over-allotment arrangements with the
Company, pursuant to which Merrill Lynch International may acquire, or procure
purchasers for, up to 5% Ordinary Shares at the Issue Price, for the purpose of
allowing Merrill Lynch International to meet over-allocations in connection with
the Global Offer and to cover short positions resulting from sales effected by
it during the stabilisation period.






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END

STAWUGMWUUPAPGG

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024